Artivion, Inc. (AORT) vs CeriBell, Inc. (CBLL)

Artivion, Inc. and CeriBell, Inc. are both Medical Devices companies. Artivion, Inc. and CeriBell, Inc. are of similar size ($1.1B and $1.1B). CeriBell, Inc. grew revenue faster over the last twelve months: 31.7% against 16.4%. Artivion, Inc. has the higher net margin (−0.67% vs −64.7%) and the higher return on invested capital (1.76% vs −229.8%). Across the 17 metrics below, Artivion, Inc. leads on 12 and CeriBell, Inc. on 5.

Valuation

Metric AORT CBLL Medical Devices median
P/E n/m n/m 23.22
P/S 2.24 9.34 2.34
P/B 2.37 7.42 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA 29.78 n/m 11.54
EV/Sales 2.86 8.27 2.24
Earnings yield (0.28%) (7.03%) (10.09%)
Free cash flow yield (1.23%) (5.89%) (8.47%)

Profitability

Metric AORT CBLL Medical Devices median
Gross margin 64.37% 88.90% 56.01%
Operating margin 4.38% (68.62%) (15.03%)
Net margin (0.67%) (64.73%) (20.40%)
Free cash flow margin (1.94%) (55.02%) (7.24%)
Return on equity (0.73%) (43.93%) (15.32%)
Return on assets (0.33%) (35.29%) (19.72%)
Return on invested capital 1.76% (229.76%) (10.33%)

Growth

Metric AORT CBLL Medical Devices median
Revenue growth (TTM) 16.40% 31.70% 8.80%
EPS growth (last fiscal year) 165.63% 56.93% 29.03%
Revenue growth, 5-year CAGR 11.75% — 15.47%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AORT CBLL Medical Devices median
Debt to equity 0.82 0.16 0.07
Current ratio 3.47 9.18 2.50
Net debt to EBITDA 2.72 2.38 0.49

Dividend

Metric AORT CBLL Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric AORT CBLL Medical Devices median
Market cap 1.07b 1.06b 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack